FTC v. Golden Sunrise Nutraceutical

Golden Sunrise Nutraceutical allegedly deceptively marketed certain products between July 2017 and July 2020. Dr. Stephen Meis, the medical director of Golden Sunrise, allegedly took part in deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19, and used false or unproven claims that other treatment plans could cure cancer and Parkinson’s disease. Golden Sunrise Nutraceutical, Golden Sunrise Pharmaceutical, and Huu Tieu were allegedly making unsupported health claims.

Summary generated from official Federal Trade Commission press release